Medical Care
Global Allergy Immunotherapies Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307398
- Pages: 105
- Figures: 115
- Views: 6
In 2024, the global market size of Allergy Immunotherapies was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
ALK
Stallergenes
HAL
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Allergy Immunotherapies in global and regional level.
Chapter 3: Detailed analysis of Allergy Immunotherapies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapies revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
ALK
Stallergenes
HAL
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Allergy Immunotherapies in global and regional level.
Chapter 3: Detailed analysis of Allergy Immunotherapies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapies revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Allergy Immunotherapies Product Introduction
1.2 Market by Type
1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Allergy Immunotherapies Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergy Immunotherapies Market Size Estimates and Forecasts
2.2 Allergy Immunotherapies Market Size by Region: 2024 Versus 2031
2.2.1 Global Allergy Immunotherapies Revenue by Region: 2020-2025
2.2.2 Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031)
2.2.3 Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Allergy Immunotherapies Revenue by Type (2020-2031)
3.1.2 Global Allergy Immunotherapies Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Allergy Immunotherapies Revenue by Application (2020-2031)
3.2.2 Global Allergy Immunotherapies Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application
3.3.2 Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application
4 Global Allergy Immunotherapies by Company
4.1 Global Allergy Immunotherapies Revenue by Company (2020-2025)
4.2 Global Allergy Immunotherapies Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Allergy Immunotherapies Companies around the World: Ranking by Revenue
4.3.2 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Allergy Immunotherapies Companies Headquarters & Product Type
4.4.1 Global Allergy Immunotherapies Companies Headquarters
4.4.2 Date of International Companies Enter into Allergy Immunotherapies Market
4.4.3 Global Allergy Immunotherapies Companies Product & Service
4.4.4 Subcutaneous Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
4.4.5 Sublingual Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
4.5 Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ALK
5.1.1 ALK Corporation Information
5.1.2 ALK Description, Business Overview
5.1.3 ALK Allergy Immunotherapies Products Offered
5.1.4 ALK Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.1.5 ALK Allergy Immunotherapies Revenue by Product in 2024
5.1.6 ALK Allergy Immunotherapies Revenue by Application in 2024
5.1.7 ALK Allergy Immunotherapies Revenue by Geographic Area in 2024
5.1.8 ALK Recent Developments
5.2 Stallergenes
5.2.1 Stallergenes Corporation Information
5.2.2 Stallergenes Description, Business Overview
5.2.3 Stallergenes Allergy Immunotherapies Products Offered
5.2.4 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.2.5 Stallergenes Allergy Immunotherapies Revenue by Product in 2024
5.2.6 Stallergenes Allergy Immunotherapies Revenue by Application in 2024
5.2.7 Stallergenes Allergy Immunotherapies Revenue by Geographic Area in 2024
5.2.8 Stallergenes Recent Developments
5.3 HAL
5.3.1 HAL Corporation Information
5.3.2 HAL Description, Business Overview
5.3.3 HAL Allergy Immunotherapies Products Offered
5.3.4 HAL Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.3.5 HAL Allergy Immunotherapies Revenue by Product in 2024
5.3.6 HAL Allergy Immunotherapies Revenue by Application in 2024
5.3.7 HAL Allergy Immunotherapies Revenue by Geographic Area in 2024
5.3.8 HAL Recent Developments
6 North America
6.1 North America Allergy Immunotherapies Market Size YoY Growth 2020-2031
6.2 North America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
6.3 North America Allergy Immunotherapies Revenue by Type (2020-2025)
6.4 North America Allergy Immunotherapies Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Allergy Immunotherapies Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Allergy Immunotherapies Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025)
7.4 Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025)
8 Europe
8.1 Europe Allergy Immunotherapies Market Size YoY Growth 2020-2031
8.2 Europe Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
8.3 Europe Allergy Immunotherapies Revenue by Type (2020-2025)
8.4 Europe Allergy Immunotherapies Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
9.2 Latin America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
9.3 Latin America Allergy Immunotherapies Revenue by Type (2020-2025)
9.4 Latin America Allergy Immunotherapies Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025)
10.4 Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Allergy Immunotherapies Supply Chain Analysis
11.2 Allergy Immunotherapies Key Raw Materials and Upstream Suppliers
11.3 Allergy Immunotherapies Clients Analysis
11.4 Allergy Immunotherapies Sales Channel and Sales Model Analysis
11.4.1 Allergy Immunotherapies Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Allergy Immunotherapies Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Allergy Immunotherapies Distributors
12 Allergy Immunotherapies Market Dynamics
12.1 Allergy Immunotherapies Industry Trends
12.2 Allergy Immunotherapies Market Drivers
12.3 Allergy Immunotherapies Market Challenges
12.4 Allergy Immunotherapies Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Allergy Immunotherapies Product Introduction
1.2 Market by Type
1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Allergy Immunotherapies Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergy Immunotherapies Market Size Estimates and Forecasts
2.2 Allergy Immunotherapies Market Size by Region: 2024 Versus 2031
2.2.1 Global Allergy Immunotherapies Revenue by Region: 2020-2025
2.2.2 Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031)
2.2.3 Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Allergy Immunotherapies Revenue by Type (2020-2031)
3.1.2 Global Allergy Immunotherapies Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Allergy Immunotherapies Revenue by Application (2020-2031)
3.2.2 Global Allergy Immunotherapies Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application
3.3.2 Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application
4 Global Allergy Immunotherapies by Company
4.1 Global Allergy Immunotherapies Revenue by Company (2020-2025)
4.2 Global Allergy Immunotherapies Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Allergy Immunotherapies Companies around the World: Ranking by Revenue
4.3.2 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Allergy Immunotherapies Companies Headquarters & Product Type
4.4.1 Global Allergy Immunotherapies Companies Headquarters
4.4.2 Date of International Companies Enter into Allergy Immunotherapies Market
4.4.3 Global Allergy Immunotherapies Companies Product & Service
4.4.4 Subcutaneous Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
4.4.5 Sublingual Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
4.5 Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ALK
5.1.1 ALK Corporation Information
5.1.2 ALK Description, Business Overview
5.1.3 ALK Allergy Immunotherapies Products Offered
5.1.4 ALK Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.1.5 ALK Allergy Immunotherapies Revenue by Product in 2024
5.1.6 ALK Allergy Immunotherapies Revenue by Application in 2024
5.1.7 ALK Allergy Immunotherapies Revenue by Geographic Area in 2024
5.1.8 ALK Recent Developments
5.2 Stallergenes
5.2.1 Stallergenes Corporation Information
5.2.2 Stallergenes Description, Business Overview
5.2.3 Stallergenes Allergy Immunotherapies Products Offered
5.2.4 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.2.5 Stallergenes Allergy Immunotherapies Revenue by Product in 2024
5.2.6 Stallergenes Allergy Immunotherapies Revenue by Application in 2024
5.2.7 Stallergenes Allergy Immunotherapies Revenue by Geographic Area in 2024
5.2.8 Stallergenes Recent Developments
5.3 HAL
5.3.1 HAL Corporation Information
5.3.2 HAL Description, Business Overview
5.3.3 HAL Allergy Immunotherapies Products Offered
5.3.4 HAL Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
5.3.5 HAL Allergy Immunotherapies Revenue by Product in 2024
5.3.6 HAL Allergy Immunotherapies Revenue by Application in 2024
5.3.7 HAL Allergy Immunotherapies Revenue by Geographic Area in 2024
5.3.8 HAL Recent Developments
6 North America
6.1 North America Allergy Immunotherapies Market Size YoY Growth 2020-2031
6.2 North America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
6.3 North America Allergy Immunotherapies Revenue by Type (2020-2025)
6.4 North America Allergy Immunotherapies Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Allergy Immunotherapies Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Allergy Immunotherapies Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025)
7.4 Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025)
8 Europe
8.1 Europe Allergy Immunotherapies Market Size YoY Growth 2020-2031
8.2 Europe Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
8.3 Europe Allergy Immunotherapies Revenue by Type (2020-2025)
8.4 Europe Allergy Immunotherapies Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
9.2 Latin America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
9.3 Latin America Allergy Immunotherapies Revenue by Type (2020-2025)
9.4 Latin America Allergy Immunotherapies Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025)
10.4 Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Allergy Immunotherapies Supply Chain Analysis
11.2 Allergy Immunotherapies Key Raw Materials and Upstream Suppliers
11.3 Allergy Immunotherapies Clients Analysis
11.4 Allergy Immunotherapies Sales Channel and Sales Model Analysis
11.4.1 Allergy Immunotherapies Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Allergy Immunotherapies Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Allergy Immunotherapies Distributors
12 Allergy Immunotherapies Market Dynamics
12.1 Allergy Immunotherapies Industry Trends
12.2 Allergy Immunotherapies Market Drivers
12.3 Allergy Immunotherapies Market Challenges
12.4 Allergy Immunotherapies Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Allergy Immunotherapies Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Allergy Immunotherapies Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Allergy Immunotherapies Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Allergy Immunotherapies Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 11. Allergy Immunotherapies Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Allergy Immunotherapies Players by Revenue (US$ Million) in 2024
Table 13. Global Allergy Immunotherapies Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 15. Global Allergy Immunotherapies Companies Headquarters
Table 16. Date of International Companies Enter into Allergy Immunotherapies Market
Table 17. Global Allergy Immunotherapies Companies Product & Service
Table 18. Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans
Table 19. ALK Corporation Information
Table 20. ALK Description and Business Overview
Table 21. ALK Allergy Immunotherapies Product
Table 22. ALK Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. ALK Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 24. ALK Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 25. ALK Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 26. ALK Recent Developments
Table 27. Stallergenes Corporation Information
Table 28. Stallergenes Description and Business Overview
Table 29. Stallergenes Allergy Immunotherapies Product
Table 30. Stallergenes Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Stallergenes Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 32. Stallergenes Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 33. Stallergenes Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 34. Stallergenes Recent Developments
Table 35. HAL Corporation Information
Table 36. HAL Description and Business Overview
Table 37. HAL Allergy Immunotherapies Product
Table 38. HAL Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. HAL Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 40. HAL Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 41. HAL Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 42. HAL Recent Developments
Table 43. North America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 44. North America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 45. North America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 46. North America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 47. Asia-Pacific Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
Table 48. Asia-Pacific Allergy Immunotherapies Revenue by Region (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 51. Europe Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 52. Europe Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 53. Europe Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 54. Europe Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 55. Latin America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 56. Latin America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 57. Latin America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 58. Latin America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 59. Middle East and Africa Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 60. Middle East and Africa Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 61. Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 62. Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 63. Allergy Immunotherapies Key Raw Materials, Industry Status and Trend
Table 64. Allergy Immunotherapies Key Raw Materials and Upstream Suppliers
Table 65. Allergy Immunotherapies Clients Status and Trend
Table 66. Allergy Immunotherapies Typical Clients
Table 67. Allergy Immunotherapies Distributors
Table 68. Allergy Immunotherapies Market Trends
Table 69. Allergy Immunotherapies Market Drivers
Table 70. Allergy Immunotherapies Market Challenges
Table 71. Allergy Immunotherapies Market Restraints
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapies Product Picture
Figure 2. Global Allergy Immunotherapies Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Allergy Immunotherapies Revenue Market Share by Type in 2024 & 2031
Figure 4. Subcutaneous Immunotherapy Product Picture
Figure 5. Sublingual Immunotherapy Product Picture
Figure 6. Global Allergy Immunotherapies Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Allergy Immunotherapies Revenue Market Share by Application in 2024 & 2031
Figure 8. Allergic Rhinitis
Figure 9. Allergic Asthma
Figure 10. Other
Figure 11. Allergy Immunotherapies Report Years Considered
Figure 12. Global Allergy Immunotherapies Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Allergy Immunotherapies Market Size (2020-2031) & (US$ Million)
Figure 14. Global Allergy Immunotherapies Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
Figure 16. Global Allergy Immunotherapies Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Allergy Immunotherapies Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031
Figure 19. Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031
Figure 20. Allergy Immunotherapies Revenue Share by Company (2024)
Figure 21. Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Subcutaneous Immunotherapy Revenue Proportion by Company in 2024
Figure 23. Sublingual Immunotherapy Revenue Proportion by Company in 2024
Figure 24. North America Allergy Immunotherapies Revenue 2020-2031 (US$ Million)
Figure 25. North America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 26. North America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Allergy Immunotherapies Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 31. Europe Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 33. Europe Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 34. Europe Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 43. Allergy Immunotherapies Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Allergy Immunotherapies Raw Materials by Region in 2024
Figure 45. Allergy Immunotherapies Distribution Channels
Figure 46. Global Allergy Immunotherapies Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Allergy Immunotherapies Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Allergy Immunotherapies Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Allergy Immunotherapies Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Allergy Immunotherapies Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Allergy Immunotherapies Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)
Table 11. Allergy Immunotherapies Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Allergy Immunotherapies Players by Revenue (US$ Million) in 2024
Table 13. Global Allergy Immunotherapies Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)
Table 15. Global Allergy Immunotherapies Companies Headquarters
Table 16. Date of International Companies Enter into Allergy Immunotherapies Market
Table 17. Global Allergy Immunotherapies Companies Product & Service
Table 18. Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans
Table 19. ALK Corporation Information
Table 20. ALK Description and Business Overview
Table 21. ALK Allergy Immunotherapies Product
Table 22. ALK Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. ALK Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 24. ALK Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 25. ALK Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 26. ALK Recent Developments
Table 27. Stallergenes Corporation Information
Table 28. Stallergenes Description and Business Overview
Table 29. Stallergenes Allergy Immunotherapies Product
Table 30. Stallergenes Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Stallergenes Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 32. Stallergenes Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 33. Stallergenes Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 34. Stallergenes Recent Developments
Table 35. HAL Corporation Information
Table 36. HAL Description and Business Overview
Table 37. HAL Allergy Immunotherapies Product
Table 38. HAL Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. HAL Revenue Proportion of Allergy Immunotherapies by Product in 2024
Table 40. HAL Revenue Proportion of Allergy Immunotherapies by Application in 2024
Table 41. HAL Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024
Table 42. HAL Recent Developments
Table 43. North America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 44. North America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 45. North America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 46. North America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 47. Asia-Pacific Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
Table 48. Asia-Pacific Allergy Immunotherapies Revenue by Region (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 51. Europe Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 52. Europe Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 53. Europe Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 54. Europe Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 55. Latin America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 56. Latin America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 57. Latin America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 58. Latin America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 59. Middle East and Africa Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
Table 60. Middle East and Africa Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
Table 61. Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)
Table 62. Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)
Table 63. Allergy Immunotherapies Key Raw Materials, Industry Status and Trend
Table 64. Allergy Immunotherapies Key Raw Materials and Upstream Suppliers
Table 65. Allergy Immunotherapies Clients Status and Trend
Table 66. Allergy Immunotherapies Typical Clients
Table 67. Allergy Immunotherapies Distributors
Table 68. Allergy Immunotherapies Market Trends
Table 69. Allergy Immunotherapies Market Drivers
Table 70. Allergy Immunotherapies Market Challenges
Table 71. Allergy Immunotherapies Market Restraints
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapies Product Picture
Figure 2. Global Allergy Immunotherapies Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Allergy Immunotherapies Revenue Market Share by Type in 2024 & 2031
Figure 4. Subcutaneous Immunotherapy Product Picture
Figure 5. Sublingual Immunotherapy Product Picture
Figure 6. Global Allergy Immunotherapies Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Allergy Immunotherapies Revenue Market Share by Application in 2024 & 2031
Figure 8. Allergic Rhinitis
Figure 9. Allergic Asthma
Figure 10. Other
Figure 11. Allergy Immunotherapies Report Years Considered
Figure 12. Global Allergy Immunotherapies Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Allergy Immunotherapies Market Size (2020-2031) & (US$ Million)
Figure 14. Global Allergy Immunotherapies Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
Figure 16. Global Allergy Immunotherapies Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Allergy Immunotherapies Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031
Figure 19. Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031
Figure 20. Allergy Immunotherapies Revenue Share by Company (2024)
Figure 21. Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Subcutaneous Immunotherapy Revenue Proportion by Company in 2024
Figure 23. Sublingual Immunotherapy Revenue Proportion by Company in 2024
Figure 24. North America Allergy Immunotherapies Revenue 2020-2031 (US$ Million)
Figure 25. North America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 26. North America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Allergy Immunotherapies Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 31. Europe Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 33. Europe Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 34. Europe Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
Figure 43. Allergy Immunotherapies Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Allergy Immunotherapies Raw Materials by Region in 2024
Figure 45. Allergy Immunotherapies Distribution Channels
Figure 46. Global Allergy Immunotherapies Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Allergy Immunotherapies Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232